PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice

The Journal of Clinical Investigation
Jingying ZhouZhiwei Chen

Abstract

Viral vector-based vaccines that induce protective CD8+ T cell immunity can prevent or control pathogenic SIV infections, but issues of preexisting immunity and safety have impeded their implementation in HIV-1. Here, we report the development of what we believe to be a novel antigen-targeting DNA vaccine strategy that exploits the binding of programmed death-1 (PD1) to its ligands expressed on dendritic cells (DCs) by fusing soluble PD1 with HIV-1 GAG p24 antigen. As compared with non-DC-targeting vaccines, intramuscular immunization via electroporation (EP) of the fusion DNA in mice elicited consistently high frequencies of GAG-specific, broadly reactive, polyfunctional, long-lived, and cytotoxic CD8+ T cells and robust anti-GAG antibody titers. Vaccination conferred remarkable protection against mucosal challenge with vaccinia GAG viruses. Soluble PD1-based vaccination potentiated CD8+ T cell responses by enhancing antigen binding and uptake in DCs and activation in the draining lymph node. It also increased IL-12-producing DCs and engaged antigen cross-presentation when compared with anti-DEC205 antibody-mediated DC targeting. The high frequency of durable and protective GAG-specific CD8+ T cell immunity induced by soluble ...Continue Reading

References

Dec 2, 1992·International Journal of Cancer. Journal International Du Cancer·M R DavisB W Robinson
Sep 22, 1998·Nature Biotechnology·H Aihara, J Miyazaki
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G WideraJ B Ulmer
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·G DeliyannisA M Lew
Jun 3, 2000·Annual Review of Immunology·S GurunathanR A Seder
Mar 23, 2001·Nature Immunology·M Moser, K M Murphy
Feb 27, 2001·Nature Immunology·Y LatchmanG J Freeman
Feb 4, 2003·Nature Reviews. Immunology·Giorgio Trinchieri
Apr 18, 2003·Current Molecular Medicine·Rebecca Voltan, Marjorie Robert-Guroff
Apr 30, 2003·The Journal of Experimental Medicine·Shengdian WangLieping Chen
Dec 4, 2003·Nature Reviews. Immunology·Martien L Kapsenberg
May 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dan H BarouchJaap Goudsmit
Jun 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michele A KutzlerDavid B Weiner
Mar 1, 2006·The Journal of Experimental Medicine·Christine TrumpfhellerRalph M Steinman
May 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emma L TurnbullPersephone Borrow
Aug 19, 2006·Nature Medicine·Lydie TrautmannRafick-Pierre Sekaly
Feb 17, 2007·Nature Immunology·Arlene H SharpeGordon J Freeman
Jan 23, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Yaoxing HuangDavid D Ho
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·David Yin-Wei LinDavid N Garboczi
Mar 8, 2008·The Journal of Clinical Investigation·Godwin NchindaRalph M Steinman
Jul 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Eszter Lázár-MolnárSteven C Almo
Dec 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Curtis J HenryElizabeth M Hiltbold
Dec 17, 2008·Nature·Vijayakumar VeluRama Rao Amara
Jan 6, 2009·Immunological Reviews·Olivier JoffreCaetano Reis e Sousa
Mar 20, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Minqi LuoZhiwei Chen
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators
Nov 18, 2009·Proceedings of the National Academy of Sciences of the United States of America·Bingbing DaiPin Wang
Mar 12, 2010·Nature·Herbert W Virgin, Bruce D Walker
Jan 5, 2011·Immunological Reviews·George Makedonas, Michael R Betts
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anitha MoorthyDeborah Persaud
Jan 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·Juliana IdoyagaRalph M Steinman

❮ Previous
Next ❯

Citations

May 14, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A Saez-CirionM Müller-Trutwin
Jan 1, 2014·Vaccines·Kenji OkudaMasaru Shimada
Nov 18, 2015·Immunological Investigations·Daniel Amsterdam
May 10, 2016·Tuberculosis·Jiansong TangZhiwei Chen
May 13, 2014·Scandinavian Journal of Immunology·D LemaJ B De Sanctis
May 19, 2016·Immunity·Frank A SchildbergArlene H Sharpe
Dec 29, 2015·Expert Review of Vaccines·Lei Li, Nikolai Petrovsky
Oct 11, 2017·Nature Reviews. Immunology·Michelle N Wykes, Sharon R Lewin
Dec 28, 2019·Viruses·Eun-Ju Ko, Marjorie Robert-Guroff
Nov 22, 2018·Frontiers in Immunology·Gilberto FilaciAntonio Di Biagio
Feb 23, 2021·Molecular Therapy Oncolytics·Zhiwu TanZhiwei Chen

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM-CSF

Methods Mentioned

BETA
flow cytometry
PCR
transfection
Protein Assay
ELISA

Software Mentioned

CellQuest
JACoP
ImageJ
ZEN

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.